12 articles for HI Ali
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents.

National Research Centre, Dokki
Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.

National Research Center
Analgesic agents without gastric damage: design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors.

Okayama University Graduate School of Medicine
HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and

Texas A&M University
Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.

Texas A&M University
Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.

National Research Centre
Synthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cells.

Cairo University
Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase.

Okayama University
Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.

National Research Centre
Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.

Damanhour University
Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of action.

Umm Al-Qura University
Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.

National Research Centre